Стр. 242 - 2

376. Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis
С virus/D.X. Johansson [etal.]//Proc. Natl. Acad. Sci. USA.-2 0 0 7 . -Vol. 104 .-
P. 16269-16274.
377. Human ehrlichiosis in Oklahoma / J.R. Harkess [et al.] // J. Infect. Dis. - 1989. -
Vol. 159. —P.576-579.
378. HumanGranulocyticAnaplasmosis andAnaplasmaphagocytophilum/J. S. Dumler
[et al.] // Emerg. Infect. Dis. - 2005. - Vol. 11, № 12 - P.246-248.
379. Human monoclonal antibody combination against SARS coronavirus: synergy and
coverage of escape mutants / J. ter Meulen [et al] // PLoS Med. - 2006. - Vol. 3. -
№ 7 . -P . 1071-1079.
380. Human monoclonal antibody to hepatitis С virus El glycoprotein that blocks virus
attachment and viral infectivity / Z.Y. Keck [et al.] // J. Virol. - 2004. - Vol. 78. -
P. 7257-7263.
381. Human recombinant neutralizing antibodies against hantaan virus G2 protein /
J. Koch [et al.] // Virology. - 2003. - Vol. 308. - P. 64-73.
382. Humoral and Cellular Immune Response to RNA Immunization with Flavivirus
Replicons Derived from Tick-Borne Encephalitis Virus / J.H. Aberle [et al.] //
J. Virol. - 2005. - Vol. 79, № 24. - P. 15107-15113.
383. Identification and characterization of a human monoclonal antibody that
potently neutralizes a broad panel o f rabies virus isolates / S.E. Sloan [et al.] //
Vaccine. - 2007. - Vol. 25. - P. 2800-2810.
384. Immunization with recombinant vaccinia viruses expressing structural and part
of the nonstructural region of tick-borne encephalitis virus cDNA protect against
lethal encephalitis / I. P. Dmitriev [et al.] // J. Biotechnol. - 1996. - Vol. 44,
№ 1 -3 . -P . 97-103.
385. Induction of protective cytotoxic T cell responses in the presence of high titers o f
virus-neutralizing antibodies: implications for passive and active immuni-zation /
P. Seiler [et al.] // J. Exp. Med. 1998. - Vol. 187. - P. 649-654.
386. Inhibition of complement-mediated Inhibition red cell lysis by immunoglobulins
is dependent on the Ig isotype and its С1 binding properties / T. Mollnes [et al.] //
Scand. J. Immunol. - 1995. - Vol. 41. - P. 449-456.
387. Inhibition of immune responses against rabies virus by monoclonal antibodies
directed against rabies virus antigens / C. L. Schumacher [et al.] // Vaccine. -
1992.-Vol. 10.-P . 754-760.
388. Intravenous immunoglobulin prophylaxis of cytomegalovirus infection in pediatric
renal transplant recipients / J. T. Flynn [et al.] // Am. J. Nephrol. - 1997. -
Vol. 17.-P . 146-152.
389. Intravenous immunoglobulin therapy for toxic-shock syndrome / W. L. Barry
[et al.] // JAMA. - 1992. - Vol. 267. - P. 3315-3317.
390. Isolation of human monoclonal antibodies that neutralize human rotavirus /
K. Higo-Moriguchi [et al.] // J. Virol. - 2004. - Vol. 78. - P. 3325-3332.
391. Jacobs, S. C. High-level expression of the tick-borne encephalitis virus NS1 protein
by using an adenovirus-based vector: protection elicited in a murine model /
S. C. Jacobs, J. R. Stephenson, G. W. Wilkinson // J. Virol. - 1992. - Vol. 66. -
P. 2086-2095.
392. Jenson, H. B. The role of intravenous immunoglobulin for the prevention and
224